Asia Pacific Erythropoietin Drugs Market Size & Forecast, 2027

Asia Pacific Erythropoietin Drugs Market By Drug Class (Biologics and Biosimilars), By Product (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa and others), By Application (Renal Diseases, Cancer, Hematology and Neurology), By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027

Published Date: June-2021 | Number of Pages: 81 | Format: PDF | Report ID: KBV-15086

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Erythropoietin Drugs Market, by Drug Class
1.4.2 Asia Pacific Erythropoietin Drugs Market, by Product
1.4.3 Asia Pacific Erythropoietin Drugs Market, by Application
1.4.4 Asia Pacific Erythropoietin Drugs Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Asia Pacific Erythropoietin Drugs Market by Drug Class
3.1 Asia Pacific Biologics Market by Country
3.2 Asia Pacific Biosimilars Market by Country

Chapter 4. Asia Pacific Erythropoietin Drugs Market by Product
4.1 Asia Pacific Epoetin-alfa Market by Country
4.2 Asia Pacific Epoetin-beta Market by Country
4.3 Asia Pacific Darbepoetin-alfa Market by Country
4.4 Asia Pacific Other Product Market by Country

Chapter 5. Asia Pacific Erythropoietin Drugs Market by Application
5.1 Asia Pacific Renal Diseases Market by Country
5.2 Asia Pacific Cancer Market by Country
5.3 Asia Pacific Hematology Market by Country
5.4 Asia Pacific Neurology Market by Country

Chapter 6. Asia Pacific Erythropoietin Drugs Market by Country
6.1 China Erythropoietin Drugs Market
6.1.1 China Erythropoietin Drugs Market by Drug Class
6.1.2 China Erythropoietin Drugs Market by Product
6.1.3 China Erythropoietin Drugs Market by Application
6.2 Japan Erythropoietin Drugs Market
6.2.1 Japan Erythropoietin Drugs Market by Drug Class
6.2.2 Japan Erythropoietin Drugs Market by Product
6.2.3 Japan Erythropoietin Drugs Market by Application
6.3 India Erythropoietin Drugs Market
6.3.1 India Erythropoietin Drugs Market by Drug Class
6.3.2 India Erythropoietin Drugs Market by Product
6.3.3 India Erythropoietin Drugs Market by Application
6.4 South Korea Erythropoietin Drugs Market
6.4.1 South Korea Erythropoietin Drugs Market by Drug Class
6.4.2 South Korea Erythropoietin Drugs Market by Product
6.4.3 South Korea Erythropoietin Drugs Market by Application
6.5 Singapore Erythropoietin Drugs Market
6.5.1 Singapore Erythropoietin Drugs Market by Drug Class
6.5.2 Singapore Erythropoietin Drugs Market by Product
6.5.3 Singapore Erythropoietin Drugs Market by Application
6.6 Malaysia Erythropoietin Drugs Market
6.6.1 Malaysia Erythropoietin Drugs Market by Drug Class
6.6.2 Malaysia Erythropoietin Drugs Market by Product
6.6.3 Malaysia Erythropoietin Drugs Market by Application
6.7 Rest of Asia Pacific Erythropoietin Drugs Market
6.7.1 Rest of Asia Pacific Erythropoietin Drugs Market by Drug Class
6.7.2 Rest of Asia Pacific Erythropoietin Drugs Market by Product
6.7.3 Rest of Asia Pacific Erythropoietin Drugs Market by Application

Chapter 7. Company Profiles
7.1 Johnson and Johnson
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental &Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Approvals:
7.2 Teva Pharmaceutical Industries Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.3 Amgen, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations, and Agreements:
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 Company Overview
7.4.1 Financial Analysis
7.4.2 Segmental and Regional Analysis
7.4.3 Research & Development Expense
7.5 Biocon Limited
7.5.1 Company Overview
7.6 Intas Pharmaceutical Ltd.
7.6.1 Company Overview
7.7 Sun Pharmaceutical Industries Ltd.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.8 Dr. Reddy’s Laboratories Ltd.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 LG Corporation (LG Life Sciences Ltd.)
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.10. Celltrion, Inc.
7.10.1 Company Overview

Purchase Report

 1500
 1800
 2520

Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities